Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-20

FDA Approved: SUNOSI — Supplemental Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

The FDA approval record concerns a supplemental application for Sunosi (solriamfetol) from Axsome Therapeutics, with the submission status shown as AP (approved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunosi (solriamfetol)

Snippet

SUPPL AP for SUNOSI (SOLRIAMFETOL)